Reaching Across the Aisle: Cardio-Oncology Advocacy and Program Building
Diego Sadler(University of Chicago), Sherry‐Ann Brown(Medical College of Wisconsin), Luis E. Raez(Florida International University), Roohi Ismail Khan(University of South Florida), Anne Blaes(University of Minnesota), Andrés J. Daniele(Universidad de Buenos Aires), Anita Arnold(St Bartholomew's Hospital), Joerg Herrmann(Mayo Clinic), Sebastian Szmit, Carolina Maria Pinto Domingues Carv Silva(Universidade de São Paulo), Arjun K. Ghosh(Royal London Hospital)
Cited by 19
Related Papers
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
|European Journal of Heart Failure|2020|767
Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC
|Journal of Thoracic Oncology|2018|661
Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer
|Journal of Thoracic Oncology|2021|642
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
|European Heart Journal|2021|589